Sepracor merges and CEO Adams jumps to Inspire

With the $2.6 billion acquisition of Sepracor by Dainippon Sumitomo drawing to a close soon, the developer's CEO is on his way over to take the helm at Raleigh, NC-based Inspire Pharmaceuticals. Adrian Adams will replace Christy Shaffer, who is leaving Inspire. The move was announced as the Japanese company disclosed that Dainippon Sumitomo Pharma America is being merged into Sepracor and named Mark Iwicki as the new CEO of the merged operation. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.